Gender-affirming hormone therapy also affected by ‘myths of E and P’

+Practice

In print

Sexual health

Gender-affirming hormone therapy also affected by ‘myths of E and P’

13 December 2023

By Massimo Giola

Wednesday 13 December 2023, 12:30 AM

Oestrogen-based gender-affirming hormone therapy has the additional challenge of myths concerning progestogen [Image: Carl Hunley Jr on Unsplash]

Sexual health specialist Massimo Giola discusses some common misunderstandings about the use of oestrogen and progestogen in transfeminine gender-diverse people

Key points, The gender-diverse community is very connected at an international level. Some myths about hormone therapy have been going around for a long time. , Pract Green w Pale Yellow

1. Nolan BJ, Frydman AS, Leemaqz SY, et al. Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study. Endocr Connect 2022;11(5):e220170.

2. Sudhakar D, Huang Z, Zietkowski M, et al. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks. Neurourol Urodyn 2023;42(5):903–20.

3. Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022;23(Suppl 1):S1–259.

How to Treat

+How to treat

FREE READ

COPD: Prevent, treat and comfort

Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management

Wednesday 26 March 2025, 12:50 AM